This is the critical mistake.
There are a large variety of products to be used with standard care, some are very cheap and some are much more expensive.
So the term of "standard of care" is very wide on a worldwide basis. It is us just vefy different, at least admit this. Moreover, the end quality of the cicatrization and the carbon based testing of the water wound sudation are part of the critical efficacy readings.
If this has been told me by a past member of the EMA would you agree more? This is the case.
But I see that you act like you know everything and especially how supervisory body works.
I see the result and the outcome. This is the problem to run trials from countries that do not have the feet in actual supervisory bodies works and internal dynamics.
It is happened in Europe and in the USA again.
But seems that the interest among the parties do not match.
This is very clear.
- Forums
- ASX - By Stock
- Procedural Mistakes or lack of public information's in reference to the EU andFDA Trial
This is the critical mistake. There are a large variety of...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FTT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online